CHM 11.1% 1.0¢ chimeric therapeutics limited

r.i.p., page-35

  1. 8,674 Posts.
    Sloan

    Totally different case. You can't compare the too.

    One is forcing the respondent into receivership.

    The other is a constructive trust case.



    Just in case you didnt know which looks likely.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.